Our fair value estimate for Amotiv is AUD 12.50 per share. This implies a fiscal 2025 P/E of 19, and an enterprise value/EBITDA of 11. We assume a midcycle dividend payout ratio of around 55% of ...

Pennington Biomedical Research Center researchers have recently published a piece in the Journal of Medical Internet Research ...

I was excited to read in Will Geschke’s report (“Everett lawmakers back universal health care bill, introduced in Olympia,” Feb. 8, The Herald) about bills in our state House and Senate that, I hope, ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...